News

FDA may limit future COVID-19 boosters to seniors, those at higher risk for complications
US Food and Drug Administration officials are changing the agency's standards for updated COVID-19 booster shots with focus ...
News On 630m
Trump administration restricts eligible COVID vaccine recipients
FDA changes COVID-19 vaccine approval policy, major trials now required for widespread use. Higher risk individuals still have access.
The Community Voice57m
FDA Approves Novavax COVID-19 Shot with Restrictions
The FDA has granted full approval for Novavax's COVID-19 vaccine, but with restrictions. Discover the details now.
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
Infectious Disease Advisor4h
FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid
The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...
FDA’s new approach raises questions about fall COVID vaccine availability
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...
FOX 32 Chicago4h
FDA will limit approval for seasonal COVID vaccines: What to know
Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy from the FDA.
Victoria Advocate5h
FDA Limits COVID-19 Boosters to Seniors, Other High-Risk Groups
WEDNESDAY May 21, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has decided that only seniors and ...
Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli
Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...